|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
The Journal of Immunology, Vol 142, Issue 6 2031-2036, Copyright © 1989 by American Association of Immunologists
ARTICLES |
J Chevalier and MD Kazatchkine
INSERM U28, Hopital Broussais, Paris, France.
The distribution of CR1 on human E was studied using label-fracture and thin section electron microscopy. CR1 was found to be organized in clusters on unfixed cells and on cells that had been prefixed with paraformaldehyde or glutaraldehyde before labeling. The number of clusters/E ranged from 8 to 20 as estimated from the examination of freeze-fracture replicas of labeled cells. Clusters contained an average of 30 to 75 gold particles on cells from two donors which expressed 462 and 586 CR1 Ag sites/cell, as determined by flow cytometry. In thin section electron micrographs, gold complexes were seen surrounding an electron-dense material protruding from the membrane which represents compact aggregates of CR1. The maximal distance between gold particles and the membrane was 100 nm, which corresponds to the estimated length of the major allotypic form of CR1, as calculated from the primary DNA sequence of the molecule. The distribution in clusters of CR1 on the E membrane may provide the basis for an enhanced affinity of C3b-CR1 interactions on the plasma membrane of the cells and may explain the preferential binding of C3b-bearing immune complexes to E in vivo.
This article has been cited by other articles:
![]() |
I. Ghiran, A. M. Glodek, G. Weaver, L. B. Klickstein, and A. Nicholson-Weller Ligation of erythrocyte CR1 induces its clustering in complex with scaffolding protein FAP-1 Blood, October 15, 2008; 112(8): 3465 - 3473. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W. Pawluczkowycz, M. A. Lindorfer, J. N. Waitumbi, and R. P. Taylor Hematin Promotes Complement Alternative Pathway-Mediated Deposition of C3 Activation Fragments on Human Erythrocytes: Potential Implications for the Pathogenesis of Anemia in Malaria J. Immunol., October 15, 2007; 179(8): 5543 - 5552. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Craig, J. N. Waitumbi, and R. P. Taylor Processing of C3b-Opsonized Immune Complexes Bound to Non-Complement Receptor 1 (CR1) Sites on Red Cells: Phagocytosis, Transfer, and Associations with CR1 J. Immunol., March 1, 2005; 174(5): 3059 - 3066. [Abstract] [Full Text] [PDF] |
||||
![]() |
C E de Carvalho Lins, L S P. Crott, J E Teixeira, and J E Barbosa Reduced erythrocyte complement receptor type 1 in systemic lupus erythematosus is related to a disease activity index and not to the presence or severity of renal disease Lupus, July 1, 2004; 13(7): 517 - 521. [Abstract] [PDF] |
||||
![]() |
C. H. Nielsen and R. G. Q. Leslie Complement's participation in acquired immunity J. Leukoc. Biol., August 1, 2002; 72(2): 249 - 261. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Xiang, J. R. Rundles, D. R. Hamilton, and J. G. Wilson Quantitative Alleles of CR1: Coding Sequence Analysis and Comparison of Haplotypes in Two Ethnic Groups J. Immunol., November 1, 1999; 163(9): 4939 - 4945. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Reinagel, M. Gezen, P. J. Ferguson, S. Kuhn, E. N. Martin, and R. P. Taylor The Primate Erythrocyte Complement Receptor (CR1) as a Privileged Site: Binding of Immunoglobulin G to Erythrocyte CR1 Does Not Target Erythrocytes for Phagocytosis Blood, February 1, 1997; 89(3): 1068 - 1077. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Alexander, B. K. Hack, P. N. Cunningham, and R. J. Quigg A Protein with Characteristics of Factor H Is Present on Rodent Platelets and Functions as the Immune Adherence Receptor J. Biol. Chem., August 17, 2001; 276(34): 32129 - 32135. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |